Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Second‐generation antipsychotic drugs for obsessive compulsive disorder

This is not the most recent version

view the current version 08 December 2010

Information

DOI:
https://doi.org/10.1002/14651858.CD008141Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 07 October 2009see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:

  1. Cochrane Common Mental Disorders Group

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Katja Komossa

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Anna M Depping

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Werner Kissling

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Stefan Leucht

    Correspondence to: Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

    [email protected]

Contributions of authors

Katja Komossa: protocol development.

Anna Mareike Depping: protocol development.

Stefan Leucht: protocol development.

Werner Kissling: protocol development.

Sources of support

Internal sources

  • Freistaat Bayern, Germany.

External sources

  • Bundesministerium für Bildung und Forschung, Germany.

Declarations of interest

Stefan Leucht: received speaker/consultancy/advisory board honoraria from SanofiAventis, BMS, EliLilly, Janssen/Johnson and Johnson, Lundbeck and Pfizer. SanofiAventis and EliLilly supported research projects by Stefan Leucht.

Katja Komossa: none to declare.

Werner Kissling: received speaker or consultancy honoraria from SanofiAventis, BMS, Lilly, Janssen, Lundbeck, Bayer and Pfizer.

Anna Mareike Depping: none to declare

Acknowledgements

We would like to thank all members of the Cochrane Depression, Anxiety and Neurosis editorial team for their editorial assistance.

Version history

Published

Title

Stage

Authors

Version

2010 Dec 08

Second‐generation antipsychotics for obsessive compulsive disorder

Review

Katja Komossa, Anna M Depping, Magdalena Meyer, Werner Kissling, Stefan Leucht

https://doi.org/10.1002/14651858.CD008141.pub2

2009 Oct 07

Second‐generation antipsychotic drugs for obsessive compulsive disorder

Protocol

Katja Komossa, Anna M Depping, Werner Kissling, Stefan Leucht

https://doi.org/10.1002/14651858.CD008141

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Adult; Humans;